TNF Pharmaceuticals, Inc. (TNFA)
$4.70-9.62%Close
SELLCRISIS · day 40
Key stats
- Market cap
- $8M
- Beta
- 2.28
- P/E (TTM)
- -0.24
- 1W
- +20.51%
- 1M
- -39.67%
- vs SPY 1W
- +20.09%
- vs SPY 1M
- -41.73%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TNFA?
- LOPJLB’s latest quantitative signal on TNF Pharmaceuticals, Inc. (TNFA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TNFA in?
- TNF Pharmaceuticals, Inc. (TNFA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does TNF Pharmaceuticals, Inc. (TNFA) do?
- TNF Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm dedicated to developing advanced therapeutic platforms that tackle the root causes of diseases, rather than just managing symptoms. Its flagship drug platform, MYMD-1, is a small molecule currently undergoing clinical trials. This platform functions by modulating the immune system to regulate TNF-alphaâa key driver of chronic i…